Sean Smith is the founder of ImmunOs Therapeutics. ImmunOs Therapeutics has raised $89M in total funding. Latest round: Series B.
Sean R. Smith is the CEO of ImmunOs Therapeutics AG, a Swiss biopharmaceutical company founded in 2014. He led the company through its Series A and Series B financing rounds. Following the Series B close, he established a U.S. subsidiary for ImmunOs Therapeutics.
Full founder directory · Investor directory · Company funding database · Fundraising library